ArticleImmuno-oncology technology2025

The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort study.

S Lobo-Martins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.